No Data
TOKYO KOKI: Summary of Financial Results for the 3rd Quarter Ending February 2025 [Japanese GAAP] (Consolidated)
Tokyo Koki Sees FY Net Y51.00M
Kasumigaseki Capital, Asahi Chemicals, Toho, Bunkyo HD (14th)
※ The above Calendar is merely a schedule and may be subject to change due to corporate circumstances. --------------------------------------- January 14 (Tuesday) <135A> VRAIN <1377> Sakata Seed <138A> Hikari Food Service <1401> mbs <1407> West HD <1418> Interlife <1419> Tama Home <1430> 1st Co.
Stocks that moved the previous day part 2: GMO-AP, San-Ai Chemical Industries, Fujio Food Group Headquarters, etc.
Disgusted by the dilution of stock value due to the implementation of public offerings.
Keisei, Mitachi, Fujio Food, etc.
<2875> Maruha Nichiro rose 70 to 10915. UBS Securities has upgraded its investment rating from 'neutral' to 'buy' and raised its target price from 10300 yen to 11700 yen. It seems that the evaluation is being increased due to the possibility that the company's transformation may not only result in dividends, but also involve business transformation, as well as the assumption that North America will continue to grow healthily without excessive competition. It is said that performance estimates for the fiscal year ending March 2026 have been revised upward and valuations are also on the rise. New in March 25.
Allied HD, etc. [Stocks with attractive valuations as seen from the change in trading volume]
Stock closing price day-on-day comparison volume*＜2635＞NFS&P500ESG4285142249280*＜1828＞Tanabe Kogyo169114778200*＜3416＞Pixta115010199500*＜6835＞Allied HD11294410300*＜7719＞Tokyo Keiki2022133000*＜175A＞WillSmart9212061700*＜1630＞Retail31040700650*＜1659＞iS US REIT354013577